WebMD.Boots.com For instance, patients treated with atorvastatin were found to have a 22% increased risk of new-onset diabetes, rosuvastatin an 18% increased risk and simvastatin a 10% increased risk, relative to pravastatin, which was used for comparison purposes.
Huffington Post Canada In fact, atorvastatin is by far — by far — the most popular statin." The possible link between taking some statins and diabetes has been seen in the past. In fact, Health Canada warned in January that statin users may have a small increased risk of ...
Nature World News However, patients on other drugs such as fluvastatin were at a 5 percent decreased risk and those on lovastatin were at a 1 percent decreased risk of developing the condition. "Compared with pravastatin, treatment with higher potency statins ...
Health.com Fluvastatin (Lescol) was associated with a 5 percent decreased risk of diabetes and lovastatin (Mevacor) a 1 percent decreased risk. In previous research, Crestor was associated with a 27 percent higher risk of diabetes, while Pravachol was linked to a ...
HealthCanal.com Atorvastatin accounted for more than half of all new statin prescriptions followed by rosuvastatin, simvastatin, pravastatin, lovastatin and fluvastatin. The study used pravastatin-treated patients as the comparison group as pravastatin has been shown ...
St. Albert Gazette Statin medications, such as atorvastatin (Lipitor), lovastatin (Mevacor), rosuvastatin (Crestor), simvastatin (Zocor), pravastatin (Pravachol) and fluvastatin (Lescol) are used among the general population to reduce the risk of heart attack and stroke ... and more »
Toronto NewsFIX A group of 44 patients received either lovastatin , simvastatin or pravastatin, or niacin – a B vitamin. Statin treatment lowered levels of 24S-hydroxycholesterol by 21 per cent and total cholesterol by 25 per cent. Niacin could lower 24S ...
Daily Mail The study involved 1.5 million people in Ontario, Canada, and the statins involved were fluvastatin, lovastatin , pravastatin, simvastatin, atorvastatin and rosuvastatin. Researchers identified 471,250 patients with no history of diabetes and who were ...
Science Daily (press release) All patients were aged 66 and over and started statin therapy between 1997 and 2010. The median age was 73 years. Follow up ended either ...
